ORGO (ORGO) Stock Price & Analysis
ORGO (ORGO) rose 4.27% to USD 1.71 as of September 8, 2026 at 09:34 UTC, according to Nexqual real-time market data.
ORGO last closed at USD 1.71; the session ranged USD 1.63–1.73 on volume of 665,542 shares. Market capitalization is —, with a 52-week range of USD 1.54–7.08 (NCM). Source: Nexqual, September 8, 2026 at 09:34 UTC.
Key Statistics (as of September 8, 2026 at 09:34 UTC)
| Price | USD 1.71 |
|---|---|
| Change | ▲ 4.27% (up) |
| Previous Close | USD 1.71 |
| Open | USD 1.71 |
| Day Range | USD 1.63 – 1.73 |
| 52-Week Range | USD 1.54 – 7.08 |
| Volume | 665,542 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ORGO)
Nexqual's technical model rates ORGO "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:34 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.92 (neutral) |
| vs SMA50 | Below (USD 2.17) |
| MACD | -0.14 (negative) |
From ORGO's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| STRO | Sutro Biopharma, Inc. | USD 20.07 | ▼ 1.95% |
| FULC | Fulcrum Therapeutics, Inc. | USD 3.85 | ▲ 0% |
| PTGX | Protagonist Therapeutics, Inc. | USD 145.72 | ▼ 0.25% |
| SLDB | Solid Biosciences Inc. | USD 10.25 | ▼ 0.34% |
| QTRX | Quanterix Corporation | USD 2.69 | ▲ 3.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:34 UTC. This page is informational and not investment advice.